Precigen, Inc.
PGENBiotechnology
$6.64+9.21%As of Oct 29vs prior close
- Market cap
- $2.4B
- P/E (TTM)
- –
- P/E (FY1)
- 110.7×
- From 52W high
- −22.43%
- EPS (LTM)
- -$1.07
- Revenue (LTM)
- $85.7M
- Net margin
- -183.98%
- Dividend yield
- 0.00%
Nomior Score
50
Steady ProfileTop 50% of the scored universe
Growth—
Quality32
Value50
Momentum93
Resilience28
Growth
−28.20%revenue a year over 9 fiscal years
YE16 $190.9MLTM $85.7M
Connections
Revenue to profitQ2 YE26
37% of revenue became net profit.
Who owns it
2funds, 1 tracked portfolio